Retraction Watch

Medscape News has partnered with Retraction Watch to provide news about scientific fraud and integrity. Retraction Watch is a project of the nonprofit Center For Scientific Integrity dedicated to exploring retractions as a window into the scientific process. The Center also created the Retraction Watch Database, the most comprehensive database of retractions available.

• Widely Covered Paper on Ranitidine-Cancer Link Retracted The authors concluded that their widely touted finding appears to have resulted from a hiccup in the way they conducted their testing.
  Retraction Watch, June 2021
• Sleuth's Work Has Led to the ID of Hundreds of Fraudulent Papers John Loadsman has been the canary in the coal mine of the anesthesiology literature.
  Retraction Watch, June 2021
• Six Years Later, Many Suspect Papers Remain Unflagged When the University of Colorado at Denver completed an investigation in 2015 into the work of a former faculty member, the school recommended that nine papers be corrected or retracted.
  Retraction Watch, June 2021
• Two Meditation Papers Retracted for Lacking Primary Outcomes Two psychology journals have retracted two papers on the health benefits of a form of transcendental meditation. The authors failed to report the primary outcome of the study underpinning the articles.
  Retraction Watch, June 2021
• 'TikTok Doc' Loses Paper on Staff Development Over Harassment Suit In November 2020 — after the alleged assaults occurred but before the lawsuit was filed — Campbell and two OHSU colleagues published a paper in The Lancet's EClinicalMedicine.
  Retraction Watch, May 2021
• Journal Obliges Authors and Yank Ketamine Study The top editor said that the notice should have said more, but it "slipped through the cracks."
  Retraction Watch, May 2021
• 'We Are Polite': When a Retraction Notice Pulls Punches Researchers in China have lost a paper on nerve blocks after finding that the work contained 'too many' errors to stand, but after it's pretty clear "too many errors" was a euphemism.
  Retraction Watch, May 2021
• Prominent Chinese Scientist Failed to Disclose Company Ties in COVID-19 Clinical Trial Paper Last May, Nanshan Zhong published results from a clinical trial that tested whether a traditional Chinese medicine could be used to treat COVID-19 patients.
  Retraction Watch, May 2021
• Elsevier to Retract Debunked Masks Study The paper was published by an exercise physiologist with no academic connection to Stanford University or the NIH in a journal that accepts "radical, speculative and non-mainstream scientific ideas."
  Retraction Watch, April 2021
• Palmitoleic Acid Paper Pulled for Data Concerns The 2014 paper purported to provide the results of "the first randomized controlled trial of purified palmitoleic acid supplementation in humans," which Tersus funded, according to this press release.
  Retraction Watch, April 2021

More